Top Markets
Coin of the day
Satsuma Pharmaceuticals, Inc. Satsuma Pharmaceuticals, Inc.

Satsuma Pharmaceuticals, Inc.

STSA
Kedudukan dalam Saham #29900
Satsuma Pharmaceuticals, Inc. is a clinical-stage biopharmaceutical firm... Satsuma Pharmaceuticals, Inc. is a clinical-stage biopharmaceutical firm dedicated to developing innovative therapies for the rapid relief of migraines. Its lead therapeutic candidate, STS101, is an integrated drug-device system comprising a proprietary dry-powder formulation of dihydroergotamine mesylate. Currently, STS101 is progressing through its pivotal SUMMIT Phase 3 efficacy trials and is designed for self-administration via a specialized, pre-filled, single-use nasal delivery device. Established in 2016, the company maintains its headquarters in South San Francisco, California.
Harga Saham
$1.10
Disegerakkan terakhir: 2023-06-07
Modal Pasaran
$19.12M
Perubahan (1 hari)
-0.90%
Perubahan (1 tahun)
0.00%
Negara
US
Perdagangan Satsuma Pharmaceuticals, Inc. (STSA)

Kategori

Sejarah pecahan saham untuk Satsuma Pharmaceuticals, Inc. (STSA)
Saham Satsuma Pharmaceuticals, Inc. (simbol: STSA) telah mengalami sejumlah 0 pecahan saham.
Pecahan saham terkini berlaku pada Aug 19, 2026.
Satu saham STSA yang dibeli sebelum Aug 19, 2026 kini bersamaan dengan 0 saham STSA.
Senarai pecahan saham
Tahun Pecahan Gandaan Gandaan Kumulatif
Tidak cukup data untuk tarikh yang disediakan.
Pecahan saham untuk syarikat pesaing atau serupa
Syarikat Bilangan pecahan saham Gandaan Kumulatif Negara
1 x2
US
0 -
NL
1 x3
AU
0 -
CH
0 -
KR